بررسی مقایسه تاثیر تزریق داخل ضایعه ی وراپامیل با تزریق داخل ضایعه ی تریامسینولون استوناید در درمان اسکارهای هیپرتروفیک و کلوئید
مقدمه:كلوييدها و اسكارهاي هايپرتروفيك ناشي از رشد بیش ازحد كلاژن پوستي به دنبال آسیب به درم هستند كه به طور معمول منجربه مشكلات زيادي از نظر جسمي، رواني و زيبايي مي شوند. روش کار: در این مطالعه کارآزمایی بالینی دوسویه کور تصادفی شده با گروه کنترل، با طراحی گروه های زوجی، 50 بیمار دارای تعداد دو یا بیشتر کلوئید مورد بررسی قرار گرفت. در گروه کنترل (50 ضایعه)، تریامسینولون استوناید (با غلظت 40 میلی گرم در میلی لیتر) با فواصل 3 هفته یکبار برای مدت زمان کلی 18 هفته تزریق شد. در گروه دیگر (50 ضایعه)، ضایعات با وراپامیل (با غلظت 5/2 میلی گرم در میلی لیتر) با همان پروتکل درمانی قبل، تحت درمان قرار گرفتند. ارزیابی اسکارها در هر جلسه و نیز در پایان ماه سوم پیگیری توسط عکس برداری های سریال و نیز اندازه گیری مقیاس اسکار ونکوور (VSS) انجام شد. نتایج: میانگین امتیاز VSS صفر تنها در گروه تریامسینولون در مورد پارامترهای ارتفاع (هفته 15) و انعطاف پذیری (هفته 15) مشاهده شد. در گروه وراپامیل رخداد درمانی (رسیدن متغیر به صفر) و حتی هیچ بهبودی قابل ملاحظه در ضایعات مشاهده نشد. نتیجه گیری: نتایج ما از توانایی وراپامیل در درمان کلوئید و اسکارهای هیپرتروفیک پشتیبانی نمی کند. كليد واژه ها : واژگان کلیدی: کلوئید، اسکار هیپرتروفیک، تریامسینولون، وراپامیل مشخصات دانشجو: نام: پردیس ساسانی رشته تحصيلي: بیماری های پوست و مو مقطع: دستیاری تخصصی گروه آموزشي پوست پست الكترونيك دانشجو: pardis_sasani@yahoo.com اساتيد راهنما و داور: استاد راهنما: خانم دکتر عابدینی اساتيد مشاور: آقای دکتر محمودی، خانم دکتر نسیمی اساتيد داور: خانم دکتر دانش پژوه، آقای دکتر صادقی نیا زمان دفاع : روز : یکشنبه تاريخ: 14/9/1395 ساعت: 12 مكان دفاع به آدرس: میدان وحدت اسلامی، بیمارستان پوست رازی، سالن آمفی تئاتر اطلاعات به زبان انگليسي Title: A comparative study of the effect of intralesional verapamil with intralesional corticosteroids in the treatment of keloids and hypertrophic scar Abstract: Background: Keloids and hypertrophic scars are due to overgrowth of dermal collagen following trauma to the skin that usually cause major physical, psychological and cosmetic problems. Methods: In this randomized double-blinded controlled trial, with a paired design, 50 patients with 2 or more keloids were studied. In control group (50 lesions), intralesional triamcinolone acetonide (40 mg/mL) was injected at three-week intervals for a total of 18 weeks. In the other group (50 lesions), lesions were treated by verapamil (2.5 mg/mL) with the same therapeutic sessions. Scar evaluation at each stage and at the end of 3 months follow up was done by serial photographic records as well as by Vancouver Scar Scale (VSS). Results: Mean zero VSS scores were achieved with only by triamcinolone in respect of scar height (w-15) and pliability (w-15). No therapeutic event (parameter =0) and even no significant improvement were seen in verapamil group. Conclusion: Our results did not support verapamil’s capability in treatment of keloid nor hypertrophic scars. Keywords: Keywords: Keloid, Hypertrophic scars, Triamcinolone, Verapamil فهرست منابع و ماخذ فارسي و لاتين: 1. Jackson IT, Bhageshpur R, DiNick V, Khan A, Bhaloo S. Investigation of recurrence rates among earlobe keloids utilizing various postoperative therapeutic modalities. Eur J Plast Surg 2001; 24(2):88-95. 2. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars. Arch Facial Plast Surg 2006; 8(6):362-8. 3. Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994;12(1):27-37. 4. Kelly AP. Keloids and hypertrophic scars. In: Parish LC, Lask GP, eds. Aesthetic Dermatology 1991; 1: 8-69. 5. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc. 1975;67(6):428-32. 6. Brissett AE, Sherris DA. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg 2001; 17(4):263-72. 7. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg 2008; 206(4):731-41. 8. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg 2007; 33(11):1291-303. 9. Niessen F, Spauwen P, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104(5):1435-58. 10. Mofikoya BO, Adeyemo WL, Abdus-salam AA. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management. Nig Q J Hosp Med 2007; 17(4): 134-9. 11. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4(1): 19-24. 12. Manuskiatti W, Fitzpatrick RE. Treatmentresponse of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002; 138(9): 1149-55. 13. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther 2004; 17(2): 212-8. 14. Doong H, Dissanayake S, Gowrishankar TR, LaBarbera MC, Lee RC. The 1996 Lindberg award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts. J Burn Care Rehabil 1996;17:497–514. 15. Boggio RF, Freitas VM, Cassiola FM, Uryabashi Marcel Machado-Santelli GM. Effect of a calcium channel clocker (verapamil) on the morphology, cytoskeleton and collagenase activity of human skin fibroblasts. Burns 2011;37:616–25. 16. Chuangsuwanich A, Gunjittisomrarn S. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids. J Med Assoc Thai. 2007;90(7):1363-7. 17. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006;32(7):907-15. 18. Agbenorku P. Triple keloid therapy: a combination of steroids, surgery and silicone gel strip/sheet for keloid treatment. Eur J Plast Surg 2000;23(3):150-1. 19. Alster TS. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 1994;32(2):186-90. 20. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 1995;345(8959):1198-1200. 21. D’Andrea F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology 2002;204(1):60-2. 22. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001;27(1):23-7. 23. Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg 2006; 32(8):1023-9. 24. Darzi MA, Chowdri NA, Kail SK, Kahn M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992;45(5):374-9. 25. Hosnuter M, Payasli C, Isikdemir A, Tekerekoglu B. The effects of onion extract on hypertrophic and keloid scars. J Wound Care 2007;16(6):251-4. 26. Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg 2001;54(7):633-5. 27. Graham GF. Cryosurgery. Clin Plast Surg 1993;20(1): 131-47. 28. Layton AM. A review on the treatment of acne vulgaris. Int J Clin Pract 2006;60(1):64-72. 29. O’Brien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2006;(1):CD003826. 30. McIntyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars—a review of the problems associated with their use. Burns 2006; 32(1):10-5. 31. Mustoe T, Cooter RD, Gold MH, et al., for the International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002;110(2):560-71. 32. Allison KP, Kiernan MN, Waters RA, Clement RM. Pulsed dye laser treatment on burn scars. Alleviation or irritation? Burns 2003;29(3):207-13. 33. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25(3): 224-32. 34. Atiyah BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 2007;31(5): 468-92. 35. Yamamoto T. Bleomycin and the skin. Br J Dermatol 2006;155(5):869-75. 36. Lee J, Jalili R, Tredget E, Demare JR, Ghahary A. Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res 2005;25(10):627-31. 37. Khoosal D, Goldman R. Vitamin E for treating children’s scars. Does it help reduce scarring? Can Fam Physician 2006;52:855-6. 38. Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in a rabbit ear model. Plast Reconstr Surg 2002;110(1):177-83. 39. Jackson BA, Shelton AJ. Pilot study evaluating topical onion extract as a treatment for postsurgical scars. Dermatol Surg 1999;25(4):267-9. 40. Beuth J, Hunzelman N, Van Leendert R, et al. Safety and efficacy of local administration of Contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. In Vivo. 2006;20(2):277-83. 41. Jurjus A, Atiyeh BS, Abdallah IM, et al. Pharmacological modulation of wound healing in experimental burns. Burns 2007;33(7):892-907. 42. Widgerow AD, Chait LA, Stals R, Stals PJ. New innovations in scar management. Aesthetic Plast Surg 2000;24(3):227-34. 43. Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil 2004;25:1-7. 44. Giugliano G, Pasquali D, Notaro A, et al. Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts. Br J Plast Surg 2003;56:804-9. 45. Yang JY, Huang CY. The effect of combined steroid and calcium channel blocker injection on human hypertrophic scars in animal model: a new strategy for the treatment of hypertrophic scars. Dermatol Surg 2010;36:1942-9. 46. Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg 1996;37:167-9. 47. Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol 2008;74(4):343–8. 48. Lee RC, Doong H, Jellema AF. The response of burn scars to intralesional verapamil: report of five cases. Arch Surg 1994;129(1):107–11. 49. Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. burns 2014; 40: 583–8. 50. Skaria AM. Prevention and Treatment of Keloids with Intralesional Verapamil. Dermatology 2004;209:71. 51. Sullivan T, Smith J, Kermode J, McIver E, et al. Rating the burn scar. J Burn Care Rehabil 1990;11: 256–60. 52. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004; 30(1): 54-6. 53. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids. A collective review. Plast Reconstr Surg 1974; 53(2): 140-54. 54. Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. J Am Acad Dermatol 1988; 19(3): 537-41. 55. Lee RC, Ping JA. Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res 1990;49(5):463–6. 56. Danielsen PL, REA SM, WOOD FM, et al. Verapamil is less effective than riamcinolone for prevention of keloid scar recurrence after excision in a randomized controlled trial. Acta Derm Venereol 2016; 96: 774–8.
منبع:پورتال دانشکده
